by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Semax, also known as Semax Heptapeptide, is a 7 amino acids peptide that has garnered significant attention in the research community. Studies have explored its potential in neuroprotection, ACTH analog, and related fields, yielding a growing body of evidence that...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Research into Selank represents a fascinating intersection of molecular biology, pharmacology, and translational science. This 7 amino acids compound has shown promise in areas ranging from tuftsin analog to BDNF modulation, making it a subject of considerable...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Among the many peptides under active investigation, PE-22-28 stands out for its unique properties and versatile research applications. Originally studied for its effects on rapid onset, researchers have since discovered connections to antidepressant, TREK-1 inhibitor,...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Dihexa (Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)) has emerged as one of the most studied peptides in modern biomedical research. With its modified hexapeptide structure, this compound has attracted attention from researchers worldwide for its potential...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
In the ever-expanding landscape of peptide research, Semax occupies a notable position. This 7 amino acids compound has been the subject of numerous studies investigating its role in BDNF increase and ACTH analog. This article provides a detailed overview of current...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Selank, also known as Selank Heptapeptide, is a 7 amino acids peptide that has garnered significant attention in the research community. Studies have explored its potential in immune support, BDNF modulation, and related fields, yielding a growing body of evidence...
